Mayo Clinic has built new biotherapy facilities to support research and manufacturing of emerging immunotherapies. Dr. Qin, with appointments in cancer biology and hematology/oncology, and as director of regenerative immunotherapies, has overseen the expansion of facilities on the Florida campus.
Attorneys from Holland & Knight, one of the largest healthcare and life sciences law practices in the U.S., presented to members of the Exchange on what healthcare entrepreneurs need to know about the different FDA regulatory pathways to market for medical software.
Dr. Kaveh Safavi, a senior managing director responsible for Accenture’s offerings for providers, health insurers, and public and private health systems globally, shares healthcare trends that will drive the sector’s evolution.
Dr. LaTonya J. Hickson established a broad kidney disease research agenda during her tenure as an innovator in Mayo Clinic’s top-ranked Nephrology program in Minnesota. Earlier this year Dr. Hickson relocated to the Florida campus, where she chairs the Division of Nephrology and Hypertension, leads cutting-edge research, and works with corporate innovators across the country to improve patient care.
Andrew Lackner, a leader within Accenture’s corporate innovation and new venture incubation practice, presented to members of the Exchange on fundraising practices and trends in the healthcare industry.
How can medical device startups benefit most from working with physicians? Professor Thatchenkery discusses key findings of research conducted with colleagues from Stanford and Harvard Business School, on the role of physician-users in supporting — or stymieing — a venture’s ability to innovate.
NBA All-Star Pau Gasol shares the important work being done by his foundation — the Gasol Foundation — to eliminate childhood obesity globally, and strategies for fighting health disparities exacerbated by COVID-19.
Entrevista de un minuto con Pau Gasol sobre cómo aprovechar la plataforma de una estrella del deporte en pro de la salud pública 29 de Septiembre de 2020 – Por Jared Mueller, Director de Mayo Clinic Innovation Exchange Además de haber sido seis veces All-Star de la NBA y haber ganado dos anillos, y de…
Partners from Holland & Knight, one of the largest healthcare and life sciences law practices in the U.S., presented to members of the Exchange on what healthcare entrepreneurs need to know about securing and protecting intellectual property.
Currently, less than 25% of donated lungs are eligible for transplantation. Dr. Jorge Mallea serves as the medical director of a new facility on the Mayo Clinic in Florida campus that will use ex-vivo lung perfusion and other emerging technologies to increase the number of lungs for transplant.